MLTX Forecast — Price Prediction for 2025. Should I Buy MLTX?
1-Day-Price-Prediction
+1.17%
1-Week Prediction
-4.23%
1-Month Prediction
+8.82%
2026 Prediction
+220.37%
2030 Prediction
+416.33%
Based on our advanced algorithm, we predict that MLTX stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $14.96, while the 1-week outlook suggests a value of $14.16. For the 1-month forecast, we project a price of $16.09. Looking further ahead, our 2026 projection estimates a value of $47.38, with a long-term 2030 forecast reaching $76.37. Stay informed and make strategic decisions with our data-driven insights!
Should I Buy MoonLake Immunotherapeutics Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. MLTX has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
MLTX stock price ended at $14.32 on Monday, after losing-3.18%
The MoonLake Immunotherapeutics stock price decreased by -3.18% on the last trading day (15 Dec 2025), dropping from 14.7099 to 14.32. Throughout the last trading session, the stock experienced a fluctuation of 2.94% , ranging from a day low of $14.29 to a day high of 14.71. The price has declined in 5 of the last 10 days, resulting in a total change of 8.08% during this period. On the last day, trading volume decrease by -1.17M shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.34M shares were traded, amounting to approximately 19.46M.
MLTX Technical Signals
MLTX(MoonLake Immunotherapeutics Corp) has 3 buy signals and 1 sell signal now. The current trend is a downtrend starting from 2025-12-08. The total price change during this trend is -4.98%. Recently, the price has dropped while volume droped, indicating a potential rebound signal. The average turnover of MLTX over the last 5 trading days is 26.17M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
MLTX Moving Average Analysis
MoonLake Immunotherapeutics's overall moving average trend leans more bearish as of Monday, December 15, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $16.02, and $17.19. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $12.22, and $11.04. A break-down below any of these levels will issue sell signals.
MLTX Short Selling Analysis
The short sale ratio of MoonLake Immunotherapeutics(MLTX) as of 10 Dec 2025 is 17.60%, rising from last trading day. With increasing price from 14.55 to 14.61. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
1
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
1.928
Bullish
Momentum (10 days)
MOM_10 > 0
1.07
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.203
Bullish
1 Bearish Signals
1 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Moving Average
Price crosses below 5-day SMA
--
Bearish
MLTX Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Month
Min. Price
Avg. Price
Max. Price
Potential ROI
Jan 2026
$52.99
$57.71
$57.87
+8.71%
Feb 2026
$51.47
$61.08
$64.60
+15.06%
Mar 2026
$54.12
$57.03
$58.55
+7.42%
Apr 2026
$50.22
$57.22
$63.72
+7.78%
May 2026
$56.52
$57.08
$63.32
+7.52%
Jun 2026
$52.95
$59.72
$63.52
+12.48%
Jul 2026
$63.91
$64.11
$72.86
+20.75%
Aug 2026
$50.63
$51.46
$57.74
-3.07%
Sep 2026
$59.68
$64.11
$69.26
+20.75%
Oct 2026
$43.26
$52.83
$62.28
-0.50%
Nov 2026
$55.25
$64.11
$67.12
+20.75%
Dec 2026
$46.62
$47.38
$48.66
-10.75%
In 2026, MoonLake Immunotherapeutics (MLTX) is anticipated to change hands in a trading channel between $43.26 and $72.86.
MoonLake Immunotherapeutics Stock Forecast 2026
Jan 2026: MLTX Stock Forecast
Potential ROI: 8.71%
In Jan 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $57.71. The price is predicted to fluctuate between a low of $52.99 and a high of $57.87.
Feb 2026: MLTX Stock Forecast
Potential ROI: 15.06%
In Feb 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $61.08. The price is predicted to fluctuate between a low of $51.47 and a high of $64.60.
Mar 2026: MLTX Stock Forecast
Potential ROI: 7.42%
In Mar 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $57.03. The price is predicted to fluctuate between a low of $54.12 and a high of $58.55.
Apr 2026: MLTX Stock Forecast
Potential ROI: 7.78%
In Apr 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $57.22. The price is predicted to fluctuate between a low of $50.22 and a high of $63.72.
May 2026: MLTX Stock Forecast
Potential ROI: 7.52%
In May 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $57.08. The price is predicted to fluctuate between a low of $56.52 and a high of $63.32.
Jun 2026: MLTX Stock Forecast
Potential ROI: 12.48%
In Jun 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $59.72. The price is predicted to fluctuate between a low of $52.95 and a high of $63.52.
Jul 2026: MLTX Stock Forecast
Potential ROI: 20.75%
In Jul 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $64.11. The price is predicted to fluctuate between a low of $63.91 and a high of $72.86.
Aug 2026: MLTX Stock Forecast
Potential ROI: -3.07%
In Aug 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $51.46. The price is predicted to fluctuate between a low of $50.63 and a high of $57.74.
Sep 2026: MLTX Stock Forecast
Potential ROI: 20.75%
In Sep 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $64.11. The price is predicted to fluctuate between a low of $59.68 and a high of $69.26.
Oct 2026: MLTX Stock Forecast
Potential ROI: -0.50%
In Oct 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $52.83. The price is predicted to fluctuate between a low of $43.26 and a high of $62.28.
Nov 2026: MLTX Stock Forecast
Potential ROI: 20.75%
In Nov 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $64.11. The price is predicted to fluctuate between a low of $55.25 and a high of $67.12.
Dec 2026: MLTX Stock Forecast
Potential ROI: -10.75%
In Dec 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $47.38. The price is predicted to fluctuate between a low of $46.62 and a high of $48.66.
MLTX Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to MoonLake Immunotherapeutics(MLTX), our algorithm predicts MLTX's 1-month price at $14.49, with an -2.02%downwardshift. Using a similarity score up to 97.65%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for MoonLake Immunotherapeutics (MLTX.O) stock, as of Sunday, December 14, 2025 , forecasts a -2.02% change over the next month, based on its high correlation with GOLD.N stock patterns. The similarity between their price movements over the analyzed periods is 97.65%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
MLTX
No data
GOLD
Down: -2.02%Similarity: 97.65%
Name
Similarity
Up/Down
GOLD.N
97.65%
-2.02%
B.N
97.65%
-2.17%
PAGP.O
97.59%
+7.72%
USNA.N
97.48%
+6.88%
OPFI.N
97.43%
-13.96%
ABEO.O
97.41%
-4.77%
UGP.N
97.37%
-5.87%
WD.N
97.37%
+2.05%
ASC.N
97.35%
+4.17%
CULP.N
97.35%
-0.11%
MLTX Seasonality Analysis
Based on MLTX's historical stock price data across all years, the probability of a positive return in December is66.67%, suggesting it maybe an ideal month to invest in MLTX. In contrast,Juneoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying MoonLake Immunotherapeutics (MLTX.O) stock in June has the highest probability of a positive return (80.00%), while January has the lowest probability (20.00%).
Performance Seasonality
The chart shows MoonLake Immunotherapeutics. (MLTX)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy MoonLake Immunotherapeutics (MLTX.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. MLTX has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying MoonLake Immunotherapeutics (MLTX.O) stock in a year?
The radar chart shows that buying MoonLake Immunotherapeutics (MLTX.O) stock in June has the highest probability of a positive return (80.00%), while January has the lowest probability (20.00%).
How has MoonLake Immunotherapeutics. (MLTX)'s stock price performed over the past three years?
MLTX's stock price rose by 447.76% in 2023,decreased by -9.07% in 2024, and went down by 73.27%in 2025.
Is MLTX a buy based on overall technical signals summary?
MLTX has 3 buy signals and 1 sell signals now. Overall the technical rating for MLTX is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of MLTX.
What is the trend of MoonLake Immunotherapeutics (MLTX)'s moving average?
MoonLake Immunotherapeutics's overall moving average trend leans more bearish as of December 15 2025, with 3 negative signals and 1 positive signal.
What is price prediction for MLTX stock next month?
The price prediction chart for MoonLake Immunotherapeutics (MLTX.O) stock, as of December 14 2025, forecasts a -2.02% change over the next month, based on its high correlation with GOLD stock patterns. The similarity between their price movements over the analyzed periods is 97.65%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for MoonLake Immunotherapeutics (MLTX) Stock?
In Dec 2026, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $47.38. The price is predicted to fluctuate between a low of $46.62 and a high of $48.66.
What is price prediction 2030 for MoonLake Immunotherapeutics (MLTX) Stock?
In Dec 2030, MoonLake Immunotherapeutics's value is forecasted to reach an average price of $76.37. The price is predicted to fluctuate between a low of $69.85 and a high of $86.21.
Negative
Positive
